Lexaria to Present and Meet with Investors One-on-One at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 Biotech Investing
/R E P E A T -- Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067/ Biotech Investing
Gilead's Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI Biotech Investing
HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer Biotech Investing
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI Biotech Investing
U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy Biotech Investing
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Five Prime Therapeutics, Inc. Biotech Investing
